Familial clustering of ovarian and endometrial cancers

被引:13
|
作者
Hemminki, K [1 ]
Granström, C
机构
[1] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden
[2] Deutsch Krebsforschungszentrum, German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany
关键词
familial risk; sibling risk; seropapillary cystadenocarcinoma; endometrioid tumour;
D O I
10.1016/S0959-8049(03)00627-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Data on the association of ovarian cancer with other cancers in families are limited, and no data are available on the involvement of specific morphological types. The nationwide Swedish Family-Cancer Database on 10.2 million individuals and 19 175 invasive ovarian cancers was used to calculate standardised incidence ratios (SIRs) and 95% confidence intervals (CIs) for familial ovarian cancer in 0-66-year-old daughters when mothers or sisters were affected. The SIR for concordant ovarian cancers was increased. When the mother or sister had breast cancer, the SIRs were 1.21 and 1.48, respectively; when they had endometrial cancer, the SIRs were 1.45 and 2.53. Multiple myeloma in the mother was associated with a risk of ovarian cancer in the daughter. The risk of endometrioid ovarian cancer was 3.40 in the daughter when the mother presented with endometrial cancer. Our data show a strong familial coupling of ovarian and endometrial cancers, which appears to be specific to the endometrioid morphology. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:90 / 95
页数:6
相关论文
共 50 条
  • [21] Prognostic Factors in Women With Synchronous Endometrial and Ovarian Cancers
    Song, Taejong
    Seong, Seok Ju
    Bae, Duk-Soo
    Kim, Jong-Hyeok
    Suh, Dong Hoon
    Lee, Keun-Ho
    Park, Sang-Yoon
    Lee, Taek Sang
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (03) : 520 - 527
  • [22] Clinicopathological characteristics of patients with synchronous ovarian and endometrial cancers
    Chaudry, S.
    Sadaf, T.
    Butt, S.
    Syed, A. A.
    Siddique, N.
    Jamshed, A.
    Kazmi, A.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S618 - S618
  • [24] Risk factors for synchronous primary endometrial and ovarian cancers
    Herrinton, LJ
    Voigt, LF
    Weiss, NS
    Beresford, SAA
    Wingo, PA
    ANNALS OF EPIDEMIOLOGY, 2001, 11 (08) : 529 - 533
  • [25] The role of aspirin in the prevention of ovarian, endometrial and cervical cancers
    Joharatnam-Hogan, Nalinie
    Cafferty, Fay H.
    Macnair, Archie
    Ring, Alistair
    Langley, Ruth E.
    WOMENS HEALTH, 2020, 16
  • [26] Lifetime ovulatory cycles and risk of ovarian and endometrial cancers
    Yang, Hannah P.
    Murphy, Kelsey
    George, Neena
    Garcia-Closas, Montserrat
    Lissowska, Jolanta
    Brinton, Louise A.
    Wentzensen, Nicolas
    CANCER RESEARCH, 2013, 73 (08)
  • [27] Synchronous primary endometrial and ovarian cancers: a case report
    Decavalas, G.
    Adonakis, G.
    Androutsopoulos, G.
    Gkogkos, P.
    Koumoundourou, D.
    Ravazoula, P.
    Kourounis, G.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2006, 27 (04) : 434 - 436
  • [28] Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers
    Brown, Susan B.
    Hankinson, Susan E.
    STEROIDS, 2015, 99 : 8 - 10
  • [29] Expression of oestrogen receptor α and β in uterine endometrial and ovarian cancers
    Sakaguchi, H
    Fujimoto, J
    Aoki, I
    Toyoki, H
    Khatun, S
    Tamaya, T
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S74 - S75
  • [30] Hormone prevention strategies for breast, endometrial and ovarian cancers
    Rice, Laurel W.
    GYNECOLOGIC ONCOLOGY, 2010, 118 (02) : 202 - 207